Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats

S. Kapoor, D. Kala, J. Svoboda, J. Daněk, A. Faridová, Z. Brnoliaková, A. Mikulecká, J. Folbergrová, J. Otáhal

. 2022 ; 71 (3) : 401-411. [pub] 20220526

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22021453

Perinatal hypoxic-ischemic insult (HII) is one of the main devastating causes of morbidity and mortality in newborns. HII induces brain injury which evolves to neurological sequelae later in life. Hypothermia is the only therapeutic approach available capable of diminishing brain impairment after HII. Finding a novel therapeutic method to reduce the severity of brain injury and its consequences is critical in neonatology. The present paper aimed to evaluate the effect of sulforaphane (SFN) pre-treatment on glucose metabolism, neurodegeneration, and functional outcome at the acute, sub-acute, and sub-chronic time intervals in the experimental model of perinatal hypoxic-ischemic insult in rats. To estimate the effect of SFN on brain glucose uptake we have performed 18F-deoxyglucose (FDG) microCT/PET. The activity of FDG was determined in the hippocampus and sensorimotor cortex. Neurodegeneration was assessed by histological analysis of Nissl-stained brain sections. To investigate functional outcomes a battery of behavioral tests was employed. We have shown that although SFN possesses a protective effect on glucose uptake in the ischemic hippocampus 24 h and 1 week after HII, no effect has been observed in the motor cortex. We have further shown that the ischemic hippocampal formation tends to be thinner in HIE and SFN treatment tends to reverse this pattern. We have observed subtle chronic movement deficit after HII detected by ladder rung walking test with no protective effect of SFN. SFN should be thus considered as a potent neuroprotective drug with the capability to interfere with pathophysiological processes triggered by perinatal hypoxic-ischemic insult.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22021453
003      
CZ-PrNML
005      
20230518083932.0
007      
ta
008      
220907s2022 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934878 $2 doi
035    __
$a (PubMed)35616041
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kapoor, Sonam $u Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic $7 _AN116975
245    14
$a The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats / $c S. Kapoor, D. Kala, J. Svoboda, J. Daněk, A. Faridová, Z. Brnoliaková, A. Mikulecká, J. Folbergrová, J. Otáhal
520    9_
$a Perinatal hypoxic-ischemic insult (HII) is one of the main devastating causes of morbidity and mortality in newborns. HII induces brain injury which evolves to neurological sequelae later in life. Hypothermia is the only therapeutic approach available capable of diminishing brain impairment after HII. Finding a novel therapeutic method to reduce the severity of brain injury and its consequences is critical in neonatology. The present paper aimed to evaluate the effect of sulforaphane (SFN) pre-treatment on glucose metabolism, neurodegeneration, and functional outcome at the acute, sub-acute, and sub-chronic time intervals in the experimental model of perinatal hypoxic-ischemic insult in rats. To estimate the effect of SFN on brain glucose uptake we have performed 18F-deoxyglucose (FDG) microCT/PET. The activity of FDG was determined in the hippocampus and sensorimotor cortex. Neurodegeneration was assessed by histological analysis of Nissl-stained brain sections. To investigate functional outcomes a battery of behavioral tests was employed. We have shown that although SFN possesses a protective effect on glucose uptake in the ischemic hippocampus 24 h and 1 week after HII, no effect has been observed in the motor cortex. We have further shown that the ischemic hippocampal formation tends to be thinner in HIE and SFN treatment tends to reverse this pattern. We have observed subtle chronic movement deficit after HII detected by ladder rung walking test with no protective effect of SFN. SFN should be thus considered as a potent neuroprotective drug with the capability to interfere with pathophysiological processes triggered by perinatal hypoxic-ischemic insult.
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    12
$a poranění mozku $7 D001930
650    _2
$a fluorodeoxyglukosa F18 $x terapeutické užití $7 D019788
650    _2
$a glukosa $7 D005947
650    _2
$a hypoxie $x komplikace $7 D000860
650    12
$a mozková hypoxie a ischemie $x diagnostické zobrazování $x farmakoterapie $7 D020925
650    _2
$a isothiokyanatany $7 D017879
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a sulfoxidy $7 D013454
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kala, David $7 xx0239100 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Svoboda, Jan, $d 1977- $7 xx0145180 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Daněk, Jan $7 _AN116976 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Faridová, Adéla $7 xx0239484 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Brnoliaková, Zuzana $u Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic $7 xx0118307
700    1_
$a Mikulecká, Anna $7 xx0070980 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Folbergrová, Jaroslava, $d 1932- $7 jn20000400705 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Otáhal, Jakub $7 xx0105144 $u Laboratory of Developmental Epileptology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic $u Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 3 (2022), s. 401-411
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35616041 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220907 $b ABA008
991    __
$a 20230518083926 $b ABA008
999    __
$a ok $b bmc $g 1851683 $s 1172721
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 71 $c 3 $d 401-411 $e 20220526 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20220907

Najít záznam

Citační ukazatele

Možnosti archivace